Literature DB >> 1697132

Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.

G Garcia1, A Smedile, K F Bergmann, J L Gerin, P B Gregory, T C Merigan, W S Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1697132      PMCID： PMC1002483     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  21 in total

1.  DNA and DNA polymerase in the core of the Dane particle of hepatitis B.

Authors:  W S Robinson
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

2.  Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.

Authors:  G Garcia; C I Smith; J I Weissberg; M Eisenberg; J Bissett; P V Nair; B Mastre; S Rosno; D Roskamp; K Waterman
Journal:  Ann Intern Med       Date:  1987-09       Impact factor: 25.391

3.  Antigens of hepatitis delta virus in the liver and serum of humans and animals.

Authors:  K F Bergmann; J L Gerin
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

4.  Physical properties of human interferon prepared in vitro and in vivo.

Authors:  T C Merigan; D F Gregory; J K Petralli
Journal:  Virology       Date:  1966-08       Impact factor: 3.616

5.  Influence of delta infection on severity of hepatitis B.

Authors:  A Smedile; P Farci; G Verme; F Caredda; A Cargnel; N Caporaso; P Dentico; C Trepo; P Opolon; A Gimson; D Vergani; R Williams; M Rizzetto
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

6.  Type D hepatitis: the clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay.

Authors:  A Smedile; M Rizzetto; K Denniston; F Bonino; F Wells; G Verme; F Consolo; B Hoyer; R H Purcell; J L Gerin
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

7.  Permanent HBsAg clearance in chronic hepatitis B viral infection following acute delta superinfection.

Authors:  K P Chin; S Govindarajan; A G Redeker
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

8.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors:  M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

9.  Serological response to the hepatitis delta virus in hepatitis D.

Authors:  M Aragona; S Macagno; F Caredda; O Crivelli; C Lavarini; E Maran; P Farci; R H Purcell; M Rizzetto
Journal:  Lancet       Date:  1987-02-28       Impact factor: 79.321

10.  Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.

Authors:  F Caredda; E Rossi; A d'Arminio Monforte; L Zampini; T Re; B Meroni; M Moroni
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.